ALB and prostate carcinoma: • Elevated CRP associates with increased risk and survival• Higher Levels are measured in platinum-resistant ovarian tumors (68)• CRP/Albumin ratios are prognostic (69)• Pre-diagnostic hsCRP levels are not predictive of risk (65)• CRP levels are not as predictive in clinically localized prostate cancer compared to advanced disease (66)• High levels associate with metastasis and worse survival (64)